Godavari Biorefineries Ltd
Godavari Biorefineries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 4 strong
The short version
Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.
From Godavari Biorefineries Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28.
- Operating cash flows in the chemical sector expected to improve and sustain due to better gross margins and debottlenecking benefits.
- Ethanol demand anticipated to grow with E20 rollout continuing and introduction of E85 and E100 fuels, supported by government policies and flex-fuel vehicles.
- Investing in additional maize/grain front-end capacity to optimize product mix and improve ethanol production flexibility.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Godavari Biorefineries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
- Exploring front-end investments in maize/grain preparation facilities to utilize idle fermentation and distillation capacity, potentially adding 160 KLPD fungible capacity within the existing 800 KLPD distillery.
- Committed to spending INR 20 crores over the next 30-33 months on drug discovery, including safety trials for a novel anticancer molecule.
2 more points management made on capital expenditure plans
Fundraising & Capital Structure
See what Godavari Biorefineries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is experiencing strong and growing demand in its bio-based specialty chemicals business both domestically and internationally.
- They are expecting sales of about INR 190 crores in the current quarter, up from INR 169 crores reported last quarter.
- Post completion of a planned INR 25 crore debottlenecking investment (expected by the start of FY28), they anticipate bio-based specialty chemicals business to reach around INR 240 crores per quarter.
2 more points management made on order book & pipeline
Godavari Biorefineries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹564 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godavari Bioref.'s management said in earlier quarters
Others in Diversified FMCG this season
- ITC Ltd (Q1 FY27)
15,384 cr., up 81% YoY . Key concall takeaways from ITC Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Hind. Unilever (Q1 FY27)
Underlying Profit After Tax (adjusted for one-offs) grew 11% this quarter, reflecting confidence in profit growth trajectory. Key concall takeaways from Hind…
- Hindustan Foods (Q1 FY27)
Significant capex of INR340 crores in FY '27, adding new capacities, especially in food & beverages (INR210 cr), ice cream (INR80 cr), and home & personal care…
Frequently Asked Questions
What were Godavari Biorefineries Ltd Q1 FY27 results?
Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.
What is Godavari Biorefineries Ltd share price analysis?
Godavari Biorefineries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.5 with a market cap of ₹1,233 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godavari Biorefineries Ltd planning capital expenditure?
Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
Keep Godavari Biorefineries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.